Literature DB >> 17554037

Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses.

H Sittana El Mubarak1,2, Selma Yüksel2, Geert van Amerongen2, Paul G H Mulder2, Maowia M Mukhtar1, Albert D M E Osterhaus1, Rik L de Swart2.   

Abstract

Both rhesus and cynomolgus macaques have been used as animal models for measles vaccination and immunopathogenesis studies. A number of studies have suggested that experimental measles virus (MV) infection induces more-characteristic clinical features in rhesus than in cynomolgus monkeys. In the present study, both macaque species were infected with two different wild-type MV strains and clinical, virological and immunological parameters were compared. The viruses used were a genotype C2 virus isolated in The Netherlands in 1991 (MV-Bil) and a genotype B3 virus isolated from a severe measles case in Sudan in 1997 (MV-Sudan). Following infection, all rhesus monkeys developed a skin rash and conjunctivitis, which were less obvious in cynomolgus monkeys. Fever was either mild or absent in both species. Virus reisolation profiles from peripheral blood mononuclear cells and broncho-alveolar lavage cells and the kinetics of MV-specific IgM and IgG responses were largely identical in the two animal species. However, in animals infected with MV-Sudan, viraemia appeared earlier and lasted longer than in animals infected with MV-Bil. This was also reflected by the earlier appearance of MV-specific serum IgM antibodies after infection with MV-Sudan. Collectively, these data show that cynomolgus and rhesus macaques are equally susceptible to wild-type MV infection, although infection in the skin seems to follow a different course in rhesus macaques. MV-Sudan proved more pathogenic for non-human primates than MV-Bil, which may render it more suitable for use in future pathogenesis studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554037     DOI: 10.1099/vir.0.82804-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Genotype-Specific Measles Transmissibility: A Branching Process Analysis.

Authors:  Sarah F Ackley; Jill K Hacker; Wayne T A Enanoria; Lee Worden; Seth Blumberg; Travis C Porco; Jennifer Zipprich
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

Review 2.  Measles virus persistence and its consequences.

Authors:  Diane E Griffin
Journal:  Curr Opin Virol       Date:  2020-05-05       Impact factor: 7.090

3.  Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.

Authors:  Fernando P Polack; Shari L Lydy; Sok-Hyong Lee; Paul A Rota; William J Bellini; Robert J Adams; Harriet L Robinson; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

4.  In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques.

Authors:  Rory D de Vries; Ken Lemon; Martin Ludlow; Stephen McQuaid; Selma Yüksel; Geert van Amerongen; Linda J Rennick; Bert K Rima; Albert D M E Osterhaus; Rik L de Swart; W Paul Duprex
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Correction of refractive errors in rhesus macaques (Macaca mulatta) involved in visual research.

Authors:  Jude F Mitchell; Chantal J Boisvert; Jon D Reuter; John H Reynolds; Mathias Leblanc
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

6.  Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.

Authors:  Linda J Rennick; Rory D de Vries; Thomas J Carsillo; Ken Lemon; Geert van Amerongen; Martin Ludlow; D Tien Nguyen; Selma Yüksel; R Joyce Verburgh; Paula Haddock; Stephen McQuaid; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus.

Authors:  Rupak Shivakoti; Debra Hauer; Robert J Adams; Wen-Hsuan W Lin; William Paul Duprex; Rik L de Swart; Diane E Griffin
Journal:  J Interferon Cytokine Res       Date:  2014-12-17       Impact factor: 2.607

8.  Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus.

Authors:  Rory D de Vries; Martin Ludlow; R Joyce Verburgh; Geert van Amerongen; Selma Yüksel; D Tien Nguyen; Stephen McQuaid; Albert D M E Osterhaus; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

9.  Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes.

Authors:  Hui Yee Greenaway; Monica Kurniawan; David A Price; Daniel C Douek; Miles P Davenport; Vanessa Venturi
Journal:  Immunol Cell Biol       Date:  2009-06-09       Impact factor: 5.126

10.  Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.

Authors:  Richard Stebbings; Michèle Février; Bo Li; Clarisse Lorin; Marguerite Koutsoukos; Edward Mee; Nicola Rose; Joanna Hall; Mark Page; Neil Almond; Gerald Voss; Frédéric Tangy
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.